Paradigm Biopharmaceuticals Ltd. (AU:PAR) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Paradigm Biopharmaceuticals Ltd. announced that Dr. Donna Skerrett has stepped down from her role as Executive Director but will continue as Chief Medical Officer, focusing on the company’s phase 3 clinical program and upcoming New Drug Application. Dr. Skerrett’s leadership has been pivotal in advancing Paradigm’s strategic initiatives, and her continued involvement is expected to bolster the company’s efforts in bringing innovative therapies to market. This development underscores Paradigm’s commitment to achieving its strategic goals in drug development.
For further insights into AU:PAR stock, check out TipRanks’ Stock Analysis page.
